{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:48:48Z","timestamp":1761155328344},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.biologicals.2009.10.006","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T09:08:26Z","timestamp":1261472906000},"page":"53-58","source":"Crossref","is-referenced-by-count":20,"title":["Health economics of blood transfusion safety \u2013 focus on sub-Saharan Africa"],"prefix":"10.1016","volume":"38","author":[{"given":"Marinus","family":"van Hulst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees Th.","family":"Smit Sibinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2009.10.006_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(07)61197-0","article-title":"Red blood cell transfusion in clinical practice","volume":"370","author":"Klein","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2009.10.006_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(07)61167-2","article-title":"Improving blood safety worldwide","volume":"370","author":"Editorial","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2009.10.006_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJM199902113400606","article-title":"Transfusion medicine. First of two parts \u2013 blood transfusion","volume":"340","author":"Goodnough","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2009.10.006_bib4","unstructured":"TRIP foundation. Transfusion reactions in patients, annual report 2005. 2006 ed. Den Haag: TRIP; 2006."},{"key":"10.1016\/j.biologicals.2009.10.006_bib5","series-title":"Serious hazards of transfusion annual report 2000\u20132001","author":"Asher","year":"2002"},{"key":"10.1016\/j.biologicals.2009.10.006_bib6","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.biologicals.2009.10.006_bib7","series-title":"AIDS epidemic update: December 2007","author":"UNAIDS","year":"2007"},{"key":"10.1016\/j.biologicals.2009.10.006_bib8","first-page":"671","article-title":"Current risk for transfusion transmitted infections","volume":"14","author":"Dodd","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.biologicals.2009.10.006_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/80394","article-title":"Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis","volume":"6","author":"Alter","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.biologicals.2009.10.006_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tmrv.2006.11.001","article-title":"Modern plasma fractionation","volume":"21","author":"Burnouf","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.biologicals.2009.10.006_bib12","series-title":"Plasma fractionation and blood transfusion","first-page":"143","article-title":"Prevention of transmission of virus infections by blood transfusions and removal of viral infectivity from clotting factor concentrates","author":"Gerety","year":"1985"},{"key":"10.1016\/j.biologicals.2009.10.006_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1537-2995.2000.40081017.x","article-title":"Public perception of the risk of blood transfusion","volume":"40","author":"Finucane","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1423-0410.2007.00941.x","article-title":"Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia","volume":"93","author":"Angelotta","year":"2007","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2009.10.006_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-136-4-200202190-00011","article-title":"Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s","volume":"136","author":"Weinberg","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biologicals.2009.10.006_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(03)12195-2","article-title":"Transfusion medicine: looking to the future","volume":"361","author":"Goodnough","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2009.10.006_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.transci.2006.01.005","article-title":"Pulmonary consequences of transfusion: TRALI and TACO","volume":"34","author":"Popovsky","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.biologicals.2009.10.006_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.21307\/immunohematology-2019-753","article-title":"Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study","volume":"12","author":"Popovsky","year":"1996","journal-title":"Immunohematol"},{"key":"10.1016\/j.biologicals.2009.10.006_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/tm.2000.7396","article-title":"Transfusion medicine in developing countries","volume":"14","author":"Sibinga","year":"2000","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.biologicals.2009.10.006_bib20","series-title":"Global database on blood safety; report 2001\u20132002","author":"WHO","year":"2004"},{"key":"10.1016\/j.biologicals.2009.10.006_bib21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/jcp.2006.042309","article-title":"Laboratory costs of a hospital-based blood transfusion service in Malawi","volume":"60","author":"Medina","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.biologicals.2009.10.006_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1423-0410.2001.00023.x","article-title":"Screening for viral markers in volunteer and replacement blood donors in West Africa","volume":"80","author":"Sarkodie","year":"2001","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2009.10.006_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1423-0410.2002.00198.x","article-title":"Pharmaco-economics of blood transfusion safety: review of the available evidence","volume":"83","author":"Van Hulst","year":"2002","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2009.10.006_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tmrv.2003.12.002","article-title":"Economic analyses of blood safety and transfusion medicine interventions: a systematic review","volume":"18","author":"Custer","year":"2004","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.biologicals.2009.10.006_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biologicals.2009.01.007","article-title":"Risk assessment and cost-effectiveness\/utility analysis","volume":"37","author":"Busch","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2009.10.006_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1778-428X.2004.tb00110.x","article-title":"The pharmacoeconomics of alternatives to allogeneic blood transfusion","volume":"6","author":"Van Hulst","year":"2004","journal-title":"Transfus Altern Transfus Med"},{"key":"10.1016\/j.biologicals.2009.10.006_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1524-4733.2001.43040.x","article-title":"Health economic guidelines \u2013 similarities, differences and some implications","volume":"4","author":"Hjelmgren","year":"2001","journal-title":"Value Health"},{"key":"10.1016\/j.biologicals.2009.10.006_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00019053-199711020-00005","article-title":"Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine","volume":"11","author":"Siegel","year":"1997","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.biologicals.2009.10.006_bib29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the Panel on Cost-effectiveness in Health and Medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.biologicals.2009.10.006_bib30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.1996.03540140060028","article-title":"The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine","volume":"276","author":"Russell","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.biologicals.2009.10.006_bib31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/(SICI)1099-1050(199709)6:5<505::AID-HEC294>3.0.CO;2-I","article-title":"Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group","volume":"6","author":"Weinstein","year":"1997","journal-title":"Health Econ"},{"key":"10.1016\/j.biologicals.2009.10.006_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1099-1050(199705)6:3<253::AID-HEC266>3.0.CO;2-6","article-title":"Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel","volume":"6","author":"Brouwer","year":"1997","journal-title":"Health Econ"},{"key":"10.1016\/j.biologicals.2009.10.006_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1099-1050(199709)6:5<511::AID-HEC297>3.0.CO;2-K","article-title":"Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion","volume":"6","author":"Brouwer","year":"1997","journal-title":"Health Econ"},{"key":"10.1016\/j.biologicals.2009.10.006_bib34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1525-1497.1998.00211.x","article-title":"Interpretation of cost-effectiveness analyses","volume":"13","author":"Owens","year":"1998","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.biologicals.2009.10.006_bib35","series-title":"Investing in health research and development: report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options","author":"WHO","year":"1996"},{"key":"10.1016\/j.biologicals.2009.10.006_bib36","series-title":"World development report 1993","author":"Bank","year":"1993"},{"key":"10.1016\/j.biologicals.2009.10.006_bib37","series-title":"Elementary economic evaluation in health care","author":"Jefferson","year":"1996"},{"key":"10.1016\/j.biologicals.2009.10.006_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(95)91272-X","article-title":"Benefits of HIV screening of blood transfusions in Zambia","volume":"346","author":"Foster","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2009.10.006_bib39","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00002030-199211000-00019","article-title":"Prevention of blood-borne HIV transmission using a decentralized approach in Shaba, Zaire","volume":"6","author":"Laleman","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.biologicals.2009.10.006_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/heapol\/14.4.354","article-title":"Feasibility of hospital-based blood banking: a Tanzanian case study","volume":"14","author":"Jacobs","year":"1999","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.biologicals.2009.10.006_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-3156.2006.01643.x","article-title":"Prevalence and screening costs of hepatitis C virus among Ugandan blood donors","volume":"11","author":"Hladik","year":"2006","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.biologicals.2009.10.006_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hpm.700","article-title":"Prioritization of prevention activities to combat the spread of HIV\/AIDS in resource constrained settings: a cost-effectiveness analysis from Chad, Central Africa","volume":"18","author":"Hutton","year":"2003","journal-title":"Int J Health Plann Manage"},{"key":"10.1016\/j.biologicals.2009.10.006_bib43","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1524-4733.2008.00337.x","article-title":"Cost-effectiveness of HIV screening of blood donations in Accra (Ghana)","volume":"11","author":"Van Hulst","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.biologicals.2009.10.006_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/j.1537-2995.2009.02351.x","article-title":"Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana,\u00a0Thailand, and the Netherlands","author":"van Hulst","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib45","first-page":"565","article-title":"Analysis of cost and effectiveness of pre-transfusion screening of donor blood and anti-malarial prophylaxis for recipients","volume":"82","author":"Rajab","year":"2005","journal-title":"East Afr Med J"},{"key":"10.1016\/j.biologicals.2009.10.006_bib46","first-page":"183","article-title":"Deferral of blood donors with risk factors for HIV infection saves lives and money in Zimbabwe","volume":"9","author":"McFarland","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.biologicals.2009.10.006_bib47","unstructured":"World Bank. GNI per capita in 2004, Atlas method and PPP. In World Development Indicators Database. Available from: http:\/\/siteresources.worldbank.org."},{"key":"10.1016\/j.biologicals.2009.10.006_bib48","author":"World Bank GNI per capita in 2008"},{"key":"10.1016\/j.biologicals.2009.10.006_bib49","first-page":"169A","article-title":"Cost-effectiveness of interventions ensuring blood transfusion safety in Africa","volume":"46","author":"Van Hulst","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tracli.2006.03.015","article-title":"Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center","volume":"13","author":"Ouattara","year":"2006","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.biologicals.2009.10.006_bib51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-3148.2007.00798.x","article-title":"Reducing replacement donors in sub-Saharan Africa: challenges and affordability","volume":"17","author":"Bates","year":"2007","journal-title":"Transfus Med"},{"key":"10.1016\/j.biologicals.2009.10.006_bib52","first-page":"261","article-title":"Cost-effectiveness of pre-donation screening blood donors with rapid tests and subsequent nucleic acid amplification testing of blood donations in a resource-poor setting","volume":"95","author":"Van Hulst","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2009.10.006_bib53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1537-2995.2000.40050585.x","article-title":"False-negative testing errors in routine viral marker screening of blood donors. For the Retrovirus Epidemiology Donor Study","volume":"40","author":"Busch","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib54","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(01)05783-X","article-title":"Estimated risk of HIV transmission by blood transfusion in Kenya","volume":"358","author":"Moore","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2009.10.006_bib55","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1046\/j.1365-3156.2000.00621.x","article-title":"Are there simple measures to reduce the risk of HIV infection through blood transfusion in a Zambian district hospital?","volume":"5","author":"Van Hoogstraten","year":"2000","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.biologicals.2009.10.006_bib56","first-page":"45","article-title":"Safety of the blood supply: an attempt to predict the value of the current infection marker screening in Kampala, Uganda","volume":"48","author":"van der Schaaf","year":"2007","journal-title":"NVB Bull"},{"key":"10.1016\/j.biologicals.2009.10.006_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/j.1537-2995.2009.02239.x","article-title":"Transfusion safety on the African continent: an international quality control of virus testing in blood banks","author":"Laperche","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib58","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.0041-1132.2004.04227.x","article-title":"Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making","volume":"44","author":"Custer","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7326\/0003-4819-143-7-200510040-00007","article-title":"The cost-effectiveness of screening the US blood supply for West Nile virus","volume":"143","author":"Custer","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biologicals.2009.10.006_bib60","series-title":"Should blood donors be tested for Variant Creutzfeldt\u2013Jakob disease?","author":"Council","year":"2006"},{"key":"10.1016\/j.biologicals.2009.10.006_bib61","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1537-2995.2004.04160.x","article-title":"Quantifying losses to the donated blood supply due to donor deferral and miscollection","volume":"44","author":"Custer","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib62","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1537-2995.2007.01292.x","article-title":"The consequences of temporary deferral on future whole blood donation","volume":"47","author":"Custer","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tmrv.2008.01.001","article-title":"Pathogen reduction: a precautionary principle paradigm","volume":"22","author":"Alter","year":"2008","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.biologicals.2009.10.006_bib64","unstructured":"Patient dies after wrong blood transfusion. NRC Handelsblad 2008; Feb 12 (in Dutch)."},{"key":"10.1016\/j.biologicals.2009.10.006_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.319.7201.16","article-title":"Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports","volume":"319","author":"Williamson","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.biologicals.2009.10.006_bib66","series-title":"Transfusion reactions in patients, annual report 2006","author":"TRIP foundation","year":"2007"},{"key":"10.1016\/j.biologicals.2009.10.006_bib67","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1537-2995.1996.36396182139.x","article-title":"A cost-effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion","volume":"36","author":"AuBuchon","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2009.10.006_bib68","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1537-2995.2006.00729.x","article-title":"End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses","volume":"46","author":"Davies","year":"2006","journal-title":"Transfusion"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105609001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105609001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T10:40:00Z","timestamp":1634380800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105609001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1045105609001560"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2009.10.006","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}